Rudziński Piotr N, Henzel Jan, Dzielińska Zofia, Lubiszewska Barbara M, Michałowska Ilona, Szymański Piotr, Pracoń Radosław, Hryniewiecki Tomasz, Demkow Marcin
Department of Coronary and Structural Heart Diseases, Institute of Cardiology, Warsaw, Poland.
Department of Radiology, Institute of Cardiology, Warsaw, Poland.
Postepy Kardiol Interwencyjnej. 2016;12(2):135-9. doi: 10.5114/aic.2016.59364. Epub 2016 May 11.
The placement of a Swan-Ganz catheter into the pulmonary artery may lead to a number of complications (2-17%). In less than 0.2% of cases Swan-Ganz catheterization results in serious vascular damage - pulmonary artery rupture (PAR). This paper presents two distinct forms of iatrogenic PAR treated endovascularly using different vascular devices.
To evaluate the effectiveness of endovascular treatment and the application of different types of vascular devices in the management of pulmonary artery rupture caused by Swan-Ganz catheterization.
In this retrospective study we evaluated 2 patients in whom Swan-Ganz catheter application was used for perioperative monitoring and resulted in pulmonary artery rupture. This complication was treated endovascularly by means of interventional cardiology.
We report the cases of 2 patients with a pulmonary artery pseudoaneurysm formed in the perioperative period. In case 1, a single, 4-loop, 3 mm diameter coil was implanted. In case 2, a 5 mm Amplatzer Vascular Plug IV was applied. In both cases, the endovascular approach resulted in total occlusion of the feeding artery and reduced further extravasation of the blood.
Despite its extremely low incidence, iatrogenic PAR is a serious, life-threatening complication of Swan-Ganz catheterization that requires urgent attention. Among available methods of treatment, percutaneous embolization is a relatively quick, safe, accurate and highly effective alternative to traumatizing surgery.
将 Swan-Ganz 导管置入肺动脉可能会导致多种并发症(发生率为 2% - 17%)。在不到 0.2%的病例中,Swan-Ganz 导管插入术会导致严重的血管损伤——肺动脉破裂(PAR)。本文介绍了使用不同血管装置经血管内治疗的两种不同形式的医源性 PAR。
评估血管内治疗的有效性以及不同类型血管装置在治疗 Swan-Ganz 导管插入术所致肺动脉破裂中的应用。
在这项回顾性研究中,我们评估了 2 例因 Swan-Ganz 导管用于围手术期监测而导致肺动脉破裂的患者。通过介入心脏病学方法对这一并发症进行了血管内治疗。
我们报告了 2 例在围手术期形成肺动脉假性动脉瘤的患者病例。病例 1 植入了单个直径 3 毫米的 4 圈线圈。病例 2 应用了 5 毫米的 Amplatzer 血管封堵器 IV 型。在这两个病例中,血管内治疗均导致供血动脉完全闭塞,并减少了进一步的血液外渗。
尽管医源性 PAR 的发生率极低,但它是 Swan-Ganz 导管插入术一种严重的、危及生命的并发症,需要紧急关注。在现有的治疗方法中,经皮栓塞是一种相对快速、安全、准确且高效的替代创伤性手术的方法。